Insulin Prices Continue To Climb.

reports that the costs of insulin have “skyrocketed by as much as 197 percent to more than 300 percent” over the past 12 years, making diabetes the country’s “most expensive chronic disease, according to a report in May from the American Diabetes Association.” Critics have accused Eli Lilly, Novo Nordisk and Sanofi-Aventis of “shadow pricing,” meaning that “when one company raises its price, the others follow suit.” Some patients have resorted to skipping doses, while others are “rationing them by taking less, or using insulin prescribed to other family members.” https://www.newsday.com/news/health/insulin-price-shortage-diabetes-diabetic-1.20639311